Edwards Lifesciences (EW) Tops Q2 EPS by 5c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $102.66 +3.31%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.49 billion.
GUIDANCE:
Edwards Lifesciences sees FY2025 EPS of $2.40-$2.50, versus the consensus of $2.47.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- CIMB Upgrades TIME dotCom Berhad (TDC:MK) to Buy
- Vericel (VCEL) Tops Q3 EPS by 21c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
